Danisco and Fonterra expand probiotic cooperation

Copenhagen / DK. (das) Danisco A/S announced that it has extended its licensing agreement with Fonterra Co-operative Group for two probiotic bacteria cultures – their premium probiotic strains Howaru® Bifido and Rhamnosus. Danisco´s agreement covers the production and marketing of their premium probiotic strains Howaru Bifido and Rhamnosus, with the new terms extending from five to ten years. The agreement also expands territory and applications meaning global access for dairy products, liquid and powdered beverages, such as juices, waters and sports drinks, dietary supplements, meats, cheeses, cereals, confectionery and straws. In addition, there will no longer be restrictions on therapeutic fields, thus broadening the scope for the development of clinical studies and health claims. Danisco first began licensing Fonterra-developed probiotics in 2001. Since then Danisco has become a key player in driving probiotic market growth by providing not only clinically documented probiotics with digestive and immune health benefits, but by also creating new-end applications.